Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis

被引:19
作者
Boivin, Guy
Goyette, Nathalie
Sergerie, Yan
Keays, Sharon
Booth, Tristan
机构
[1] CHU Laval, Infect Dis Res Ctr, Ste Foy, PQ G1V 4G2, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Royalmount Pharma, Montreal, PQ, Canada
关键词
herpes simplex virus; herpes labialis; viral load; real-time PCR;
D O I
10.1016/j.jcv.2006.09.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Few studies have performed sequential evaluation of the herpes simplex virus (HSV) load using quantitative PCR during episodes of herpes labialis. Objective: To determine HSV viral load kinetics during recurrences of herpes labialis. Study design: Twenty-two subjects were monitored by daily swabs during recurrences of herpes labialis. A real-time PCR detecting both HSV-1 and HSV-2 was used to quantify the viral load. Results: Median duration of HSV-1 shedding was 60 h and 48 h by PCR and culture, respectively. No HSV-2 DNA was detected in that study. Peak viral DNA load (123.6 copies/cell) occurred at 48 h with no virus detected beyond 96 h of onset of symptoms. Conclusions: These viral load kinetics data could be used as surrogate markers of antiviral activity in future clinical trials. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 13 条
[1]   Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and pyrosequencing [J].
Adelson, ME ;
Feola, M ;
Trama, J ;
Tilton, RC ;
Mordechai, E .
JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (01) :25-34
[2]   Once-daily valacyclovir to reduce the risk of transmission of genital herpes [J].
Corey, L ;
Wald, A ;
Patel, R ;
Sacks, SL ;
Tyring, SK ;
Warren, T ;
Douglas, JM ;
Paavonen, J ;
Morrow, RA ;
Beutner, KR ;
Stratchounsky, LS ;
Mertz, G ;
Keene, ON ;
Watson, HA ;
Tait, D ;
Vargas-Cortes, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :11-20
[3]   Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time Taqman PCR assay [J].
Corey, L ;
Huang, ML ;
Selke, S ;
Wald, A .
JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (03) :350-355
[4]  
Filén F, 2004, SEX TRANSM DIS, V31, P331, DOI 10.1097/00007435-200406000-00002
[5]   Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men [J].
Kim, H. Nina ;
Meier, Amalia ;
Huang, Meei-Li ;
Kuntz, Steve ;
Selke, Stacy ;
Celum, Connie ;
Corey, Lawrence ;
Wald, Anna .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (04) :420-427
[6]   Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates [J].
Löwhagen, GB ;
Tunbäck, P ;
Bergström, T .
ACTA DERMATO-VENEREOLOGICA, 2002, 82 (02) :118-120
[7]   The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures [J].
Miller, CS ;
Cunningham, LL ;
Lindroth, JE ;
Avdiushko, SA .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2004, 135 (09) :1311-1318
[8]   Topical undecylenic acid for herpes simplex labialis: A multicenter, placebo-controlled trial [J].
Shafran, SD ;
Sacks, SL ;
Aoki, FY ;
Tyrrell, DL ;
Schlech, WF ;
Mendelson, J ;
Rosenthal, D ;
Gill, MJ ;
Bader, RL ;
Chang, I .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :78-83
[9]   High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: Results of two randomized, placebo-controlled, multicenter studies [J].
Spruance, SL ;
Jones, TM ;
Blatter, MM ;
Vargas-Cortes, M ;
Barber, J ;
Hill, J ;
Goldstein, D ;
Schultz, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1072-1080
[10]   Penciclovir cream for the treatment of herpes simplex labialis - A randomized, multicenter, double-blind, placebo-controlled trial [J].
Spruance, SL ;
Rea, TL ;
Thoming, C ;
Tucker, R ;
Saltzman, R ;
Boon, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17) :1374-1379